Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life

Rasika Kordea School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA

Rajwanth Veluswamyb Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, NY, USA;c Tisch Cancer Institute and Icahn School of Medicine, Center for Thoracic Oncology, Mount Sinai, NY, USA;d Icahn School of Medicine at Mount Sinai, Institute for Translational Epidemiology, Mount Sinai, NY, USACorrespondence[email protected]

Jason C. Allairee Health Economics and Patient Outcomes, Generativity Health Economics and Outcomes Research, Durham, USA;f Department of Psychology, North Carolina State University, Raleigh, NC, USA

Gisoo Barnesg BeiGene, Ltd., Health Economics and Outcomes Research, Emeryville, CA, USA

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date